Palisade Bio (PALI) Capital Expenditures (2010 - 2022)

Palisade Bio's (PALI) quarterly Capital Expenditures came in at $10000.0 in Q4 2022, up 900.0% on a QoQ basis from $1000.0 in Q4 2020.

Palisade Bio (PALI) Capital Expenditures (2010 - 2022) Analysis & Trends

Palisade Bio (PALI) has 12 years of Capital Expenditures data on file, last reported at $10000.0 in Q4 2022.

  • On a quarterly basis, Capital Expenditures changed N/A year-over-year to $10000.0 in Q4 2022; TTM through Sep 2024 was $10000.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at $4000.0, down 60.0% from the prior year.
  • Capital Expenditures for Q4 2022 stood at $10000.0, up from $1000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for PALI reached as high as $10000.0 in Q4 2022 and fell as low as -$22381.0 in Q2 2019.
  • Historically, Capital Expenditures has averaged -$4256.0 across 4 years, with a median of -$1000.0 in 2020.
  • Across the five-year window, Capital Expenditures soared 2415.72% in 2018 and tumbled 578.12% in 2019, its largest moves.
  • Year by year, Capital Expenditures stood at -$2286.0 in 2018, then tumbled by 879.05% to -$22381.0 in 2019, then jumped by 104.47% to $1000.0 in 2020, then jumped by 900.0% to $10000.0 in 2022.
  • Per Business Quant data, the three most recent Capital Expenditures figures were $10000.0 in Q4 2022, $1000.0 in Q4 2020, and -$1000.0 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Palisade Bio 985.76 -132.63 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 10,000.00
Dec 31, 2022 10,000.00
Dec 31, 2020 1,000.00
Dec 31, 2020 1,000.00
Sep 30, 2020 -1,000.00
Sep 30, 2020 -1,000.00
Jun 30, 2019 -22,381.00
Jun 30, 2019 -22,381.00
Mar 31, 2019 -19,125.00
Mar 31, 2019 -19,125.00
Dec 31, 2018 -2,286.00
Dec 31, 2018 -2,286.00
Mar 31, 2018 4,000.00
Mar 31, 2018 4,000.00
Dec 31, 2017 -12,848.00
Dec 31, 2017 -12,848.00
Sep 30, 2017 12,964.00
Sep 30, 2017 12,964.00
Jun 30, 2017 -2,130.00
Jun 30, 2017 -2,130.00